MTOR and prostate carcinoma: Cumulatively, these data show that mTOR-S2448 phosphorylation is indicative for an activated mTOR pathway in prostate cancer, and this mTOR signaling pathway is activated specifically in prostate cancer patients with a favorable outcome.